Bio-Techne (TECH) Current Taxes (2010 - 2026)
Bio-Techne (TECH) posted quarterly Current Taxes of $3.0 million for Q1 2026, down 18.11% year-over-year from $3.6 million in Q1 2025, and up 19.99% quarter-over-quarter from $2.5 million in Q4 2025.
Bio-Techne (TECH) Current Taxes (2010 - 2026) Analysis & Trends
Bio-Techne's Current Taxes history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Current Taxes fell 18.11% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 18.11% YoY), while the FY2025 annual figure was $10.8 million, up 190.61% from the prior year.
- Current Taxes for Q1 2026 stood at $3.0 million, up from $2.5 million in the prior quarter.
- The five-year high for Current Taxes was $25.3 million in Q4 2022, with the low at $2.5 million in Q4 2025.
- The 5-year median for Current Taxes is $6.6 million (2023), against an average of $9.0 million.
- The sharpest annual moves came in 2023 and 2025: Current Taxes plunged 73.71% in 2023, then surged 190.61% in 2025.
- Bio-Techne's Current Taxes stood at $25.3 million in 2022, then slumped by 73.71% to $6.6 million in 2023, then plunged by 52.74% to $3.1 million in 2024, then retreated by 21.17% to $2.5 million in 2025, then increased by 19.99% to $3.0 million in 2026.
- Business Quant data shows TECH's Current Taxes at $3.0 million in Q1 2026, $2.5 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 10.77 Mn |
| Mar 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 12.08 Mn |
| Dec 31, 2023 | 6.65 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 12.02 Mn |
| Mar 31, 2023 | 18.17 Mn |
| Dec 31, 2022 | 25.28 Mn |
| Sep 30, 2022 | 17.27 Mn |
| Jun 30, 2022 | 13.24 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | 14.28 Mn |
| Sep 30, 2021 | 6.51 Mn |
| Jun 30, 2021 | 5.34 Mn |